Home >> MARKETPLACE >> LGC launches Accurun MS2 internal control

LGC launches Accurun MS2 internal control

image_pdfCreate PDF

July 2023—LGC Clinical Diagnostics has launched the SeraCare Accurun MS2, a full-process internal control that can be used as a tool to monitor the process integrity of sample extraction and amplification of nucleic acid amplification–based assays. The product contains positive materials of intact MS2 bacteriophage, and the ready-to-use controls can be spiked into specimens that are going through DNA/RNA extraction.

LGC Clinical Diagnostics, 508-244-6400

CAP TODAY
X